Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 5426 - 5450 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ▼ ChEBI ID Exact Mass Formula
Diacylglycerophosphoinositolglycans LMGP15010068
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/14:0)
126457436 1132.615833 C53H97O23P
Diacylglycerophosphoinositolglycans LMGP15010067
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/18:1(9Z))
126457435 1188.678433 C57H105O23P
Diacylglycerophosphoinositolglycans LMGP15010066
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/18:0)
126457434 1190.694083 C57H107O23P
Diacylglycerophosphoinositolglycans LMGP15010065
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/16:2(9Z,12Z))
126457433 1158.631483 C55H99O23P
Diacylglycerophosphoinositolglycans LMGP15010064
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/16:1(9Z))
126457432 1160.647133 C55H101O23P
Diacylglycerophosphoinositolglycans LMGP15010063
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/16:0)
126457431 1162.662783 C55H103O23P
Diacylglycerophosphoinositolglycans LMGP15010062
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/14:0)
126457430 1134.631483 C53H99O23P
Diacylglycerophosphoinositolglycans LMGP15010061
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/18:1(9Z))
126457429 1174.662783 C56H103O23P
Diacylglycerophosphoinositolglycans LMGP15010060
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/18:0)
126457428 1176.678433 C56H105O23P
Diacylglycerophosphoinositolglycans LMGP15010059
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/16:2(9Z,12Z))
126457427 1144.615833 C54H97O23P
Diacylglycerophosphoinositolglycans LMGP15010058
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/16:1(9Z))
126457426 1146.631483 C54H99O23P
Diacylglycerophosphoinositolglycans LMGP15010057
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/16:0)
126457425 1148.647133 C54H101O23P
Diacylglycerophosphoinositolglycans LMGP15010056
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/14:0)
126457424 1120.615833 C52H97O23P
Diacylglycerophosphoinositolglycans LMGP15010055
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/18:1(9Z))
126457423 1160.647133 C55H101O23P
Diacylglycerophosphoinositolglycans LMGP15010054
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/18:0)
126457422 1162.662783 C55H103O23P
Diacylglycerophosphoinositolglycans LMGP15010053
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/16:2(9Z,12Z))
126457421 1130.600183 C53H95O23P
Diacylglycerophosphoinositolglycans LMGP15010052
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/16:1(9Z))
126457420 1132.615833 C53H97O23P
Diacylglycerophosphoinositolglycans LMGP15010051
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/16:0)
126457419 1134.631483 C53H99O23P
Diacylglycerophosphoinositolglycans LMGP15010050
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/14:0)
126457418 1106.600183 C51H95O23P
Diacylglycerophosphoinositolglycans LMGP15010049
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/18:1(9Z))
126457417 1036.609958 C52H93O18P
Diacylglycerophosphoinositolglycans LMGP15010048
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/18:0)
126457416 1038.625608 C52H95O18P
Diacylglycerophosphoinositolglycans LMGP15010047
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/16:2(9Z,12Z))
126457415 1006.563008 C50H87O18P
Diacylglycerophosphoinositolglycans LMGP15010046
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/16:1(9Z))
126457414 1008.578658 C50H89O18P
Diacylglycerophosphoinositolglycans LMGP15010045
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/16:0)
126457413 1010.594308 C50H91O18P
Diacylglycerophosphoinositolglycans LMGP15010044
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/14:0)
126457412 982.563008 C48H87O18P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024